I think NNZ2591 is worth a lot more than 1.5b at the current stage of the development. You can refer to my post here regarding a recent deal on a phase 3 ready asset for a rare disorder. It's sold for nearly $1b USD and disorder has two existing products in market. Based on this, PMS and Pitt Hopkins alone would be worth well over $2b USD given they have no competition and almost phase 3 ready.
https://hotcopper.com.au/threads/the-whens-and-whys-of-top-biotech-m-a-deals.8141625/
Share Price, page-11421
-
- There are more pages in this discussion • 641 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.27 |
Change
0.920(6.41%) |
Mkt cap ! $1.951B | |||
| Open | High | Low | Value | Volume |
| $14.35 | $15.27 | $14.35 | $8.720M | 579.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $15.25 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.27 | 3638 | 4 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |